Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments
20 Junio 2024 - 6:00AM
Augmedix (Nasdaq: AUGX), a leader in ambient AI medical
documentation and data solutions, announced today that Emergency
Services Inc., a physician-owned emergency medicine services group
in Columbus, Ohio, is introducing Augmedix Go ED to physicians in
the emergency department (ED) at the second-largest healthcare
system in central Ohio.
Augmedix Go ED is the industry’s first fully
automated, generative AI (GenAI) powered medical documentation
product for EDs nationwide.
“Given the unique needs of the ED, it has been
difficult to identify a documentation solution that effectively
alleviates the administrative burden on our physicians – until we
were introduced to Augmedix Go ED,” said Eric Drobny, MD, CFO at
Emergency Services Inc. “Emergency departments are noisy and
fast-paced environments, and patient visits often involve multiple,
fragmented interactions with several clinicians. We anticipate that
Augmedix Go ED will allow us to automate documentation in this
challenging environment, which will reduce the burden on our
clinicians so that they can provide the best care possible.”
This announcement comes on the heels of the
launch of Augmedix Go ED. Clinicians reported a significant
reduction in administrative burden, noting that the GenAI
technology’s high accuracy and overall quality of the medical notes
met their needs in EDs.
“Our partnership with Emergency Services Inc.
highlights our dedication to delivering leading-edge GenAI products
in an area of healthcare that is lacking effective solutions:
emergency medicine,” said Manny Krakaris, CEO of Augmedix.
“Emergency Services Inc. is an ideal partner for us because they
prioritize the well-being and positive experiences of their
clinicians, and ultimately, patients.”
For more information about Augmedix Go ED, visit
augmedix.com/augmedix-go-ed.
About Emergency Services Inc.
Emergency Services Inc. is a physician-owned
emergency medicine services group in Columbus, Ohio. Being
physician-led makes all the difference. Our certified emergency
medical experts value teamwork, collaboration and family. By
working together, we're making healthcare work better for all of
Ohio.
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to
connect with patients by liberating them from administrative burden
through the power of ambient AI, data, and trust.
The platform transforms natural conversations
into organized medical notes, structured data, and point-of-care
notifications that enhance efficiency and clinical decision
support.
Incorporating data from millions of interactions
across all care settings, Augmedix collaborates with hospitals and
health systems to improve clinical, operational, and financial
outcomes.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
Forward-Looking Statements
This press release contains “forward-looking
statements” that involve a number of risks and uncertainties. Words
such as “believes,” “may,” “will,” “estimates,” “potential,”
“continues,” “anticipates,” “intends,” “expects,” “could,” “would,”
“projects,” “plans,” “targets,” “excited,” “optimistic,” and
variations of such words and similar expressions are intended to
identify forward-looking statements. Such forward-looking
statements include, without limitation, statements regarding the
significant reduction in administrative burden clinicians will
experience with Augmedix Go for EDs; Augmedix Go for EDs allowing
clinicians to automate documentation so that they can provide the
best care possible; GenAI technology’s high accuracy and overall
quality of the medical notes meeting the needs of clinicians in
EDs; Augmedix’s dedication to delivering leading-edge GenAI
products in emergency medicine; and Emergency Services Inc. being
an ideal partner for Augmedix. Actual results could differ
materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited
to, risks detailed in our most recent Form 10-K filed with the U.S.
Securities and Exchange Commission on March 26, 2024, as well as
other documents that may be filed by us from time to time with the
U.S. Securities and Exchange Commission. The forward-looking
statements included in this press release represent our views as of
the date of this press release. We undertake no intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
These forward-looking statements should not be relied upon as
representing our views as of any date subsequent to the date of
this press release.
Contact Information
Investors:Matt Chesler, CFAFNK
IR646-809-2183augx@fnkir.cominvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Augmedix (NASDAQ:AUGX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024